SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-052146
Filing Date
2024-06-12
Accepted
2024-06-12 17:09:59
Documents
4
Period of Report
2024-07-29

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0207269-02.htm DEF 14A 1335658
2 GRAPHIC tproxy_001.jpg GRAPHIC 1159146
3 GRAPHIC tproxy_002.jpg GRAPHIC 952772
4 GRAPHIC tvirpax_logo.jpg GRAPHIC 89395
  Complete submission text file 0001213900-24-052146.txt   4369487
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40064 | Film No.: 241039227
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)